Eden Research plc (LON:EDEN – Get Free Report) shot up 2.8% during mid-day trading on Tuesday following insider buying activity. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). 12,234,783 shares were traded during mid-day trading, an increase of 664% from the average session volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey purchased 540,540 shares of the stock in a transaction on Tuesday, January 28th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,902.58).
Eden Research Stock Performance
The company has a market cap of £19.73 million, a PE ratio of -200.00 and a beta of 0.92. The business has a fifty day moving average of GBX 3.88 and a 200-day moving average of GBX 4.01. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.25.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Further Reading
- Five stocks we like better than Eden Research
- What is the Euro STOXX 50 Index?
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- What Does the Future Hold for Eli Lilly?
- What Does Downgrade Mean in Investing?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
